The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Glycated Albumin Market Research Report 2024
Synopsis
Diabetes afflicts an increasing number of people worldwide each year. Proper blood glucose control is essential in preventing complications associated with diabetes, such as neuropathy, nephropathy and retinopathy.
Glycation is the result of a sugar molecule, such as fructose or glucose, bonding to a protein or lipid molecule without the controlling action of an enzyme. It is a haphazard process that impairs the functioning of biomolecules. The high levels of glucose present in diabetes meatus results in increased glycation of all proteins, including, albumin. Measurement of the amount of the glycation reaction resulting from the combination of glucose with free amino groups in proteins present in the blood is used to monitor the level of glucose that has generally been present in body fluids over a preceding period.
Thus serum glycated albumin assay can be used to determine the current level of glycation of albumin, the most abundant plasma protein. Hence, the gycated albumin assay may be used as a marker of glycemic control in diabetes and reflects glycemic control over the precious 2 to 4 weeks.
The global Glycated Albumin market was valued at US$ 429 million in 2023 and is anticipated to reach US$ 602 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.
The major players in global Glycated Albumin market include Asahi Kasei Pharma, DIAZYME, Abnova, etc. The top 3 players occupy about 85% shares of the global market. Asia-Pacific and Europe are main markets, they occupy about 60% of the global market. Glycated Albumin (Animal) is the main type, with a share about 60%. Hospitals and Clinics is the main application, which holds a share about 50%.
This report aims to provide a comprehensive presentation of the global market for Glycated Albumin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glycated Albumin.
Report Scope
The Glycated Albumin market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glycated Albumin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glycated Albumin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Asahi Kasei Pharma
DIAZYME
Abnova
LifeSpan
Exocell
BSBE
Medicalsystem
Maccura
Leadman
Simes Sikma
NINGBO PUREBIO
Segment by Type
Glycated Albumin (Human)
Glycated Albumin (Animal)
Segment by Application
Hospitals and Clinics
Laboratories
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glycated Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glycated Albumin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Diabetes afflicts an increasing number of people worldwide each year. Proper blood glucose control is essential in preventing complications associated with diabetes, such as neuropathy, nephropathy and retinopathy.
Glycation is the result of a sugar molecule, such as fructose or glucose, bonding to a protein or lipid molecule without the controlling action of an enzyme. It is a haphazard process that impairs the functioning of biomolecules. The high levels of glucose present in diabetes meatus results in increased glycation of all proteins, including, albumin. Measurement of the amount of the glycation reaction resulting from the combination of glucose with free amino groups in proteins present in the blood is used to monitor the level of glucose that has generally been present in body fluids over a preceding period.
Thus serum glycated albumin assay can be used to determine the current level of glycation of albumin, the most abundant plasma protein. Hence, the gycated albumin assay may be used as a marker of glycemic control in diabetes and reflects glycemic control over the precious 2 to 4 weeks.
The global Glycated Albumin market was valued at US$ 429 million in 2023 and is anticipated to reach US$ 602 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.
The major players in global Glycated Albumin market include Asahi Kasei Pharma, DIAZYME, Abnova, etc. The top 3 players occupy about 85% shares of the global market. Asia-Pacific and Europe are main markets, they occupy about 60% of the global market. Glycated Albumin (Animal) is the main type, with a share about 60%. Hospitals and Clinics is the main application, which holds a share about 50%.
This report aims to provide a comprehensive presentation of the global market for Glycated Albumin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glycated Albumin.
Report Scope
The Glycated Albumin market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glycated Albumin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glycated Albumin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Asahi Kasei Pharma
DIAZYME
Abnova
LifeSpan
Exocell
BSBE
Medicalsystem
Maccura
Leadman
Simes Sikma
NINGBO PUREBIO
Segment by Type
Glycated Albumin (Human)
Glycated Albumin (Animal)
Segment by Application
Hospitals and Clinics
Laboratories
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glycated Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glycated Albumin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Glycated Albumin Market Overview
1.1 Product Overview and Scope of Glycated Albumin
1.2 Glycated Albumin Segment by Type
1.2.1 Global Glycated Albumin Market Value Comparison by Type (2024-2030)
1.2.2 Glycated Albumin (Human)
1.2.3 Glycated Albumin (Animal)
1.3 Glycated Albumin Segment by Application
1.3.1 Global Glycated Albumin Market Value by Application: (2024-2030)
1.3.2 Hospitals and Clinics
1.3.3 Laboratories
1.4 Global Glycated Albumin Market Size Estimates and Forecasts
1.4.1 Global Glycated Albumin Revenue 2019-2030
1.4.2 Global Glycated Albumin Sales 2019-2030
1.4.3 Global Glycated Albumin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Glycated Albumin Market Competition by Manufacturers
2.1 Global Glycated Albumin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Glycated Albumin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Glycated Albumin Average Price by Manufacturers (2019-2024)
2.4 Global Glycated Albumin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Glycated Albumin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glycated Albumin, Product Type & Application
2.7 Glycated Albumin Market Competitive Situation and Trends
2.7.1 Glycated Albumin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Glycated Albumin Players Market Share by Revenue
2.7.3 Global Glycated Albumin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glycated Albumin Retrospective Market Scenario by Region
3.1 Global Glycated Albumin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Glycated Albumin Global Glycated Albumin Sales by Region: 2019-2030
3.2.1 Global Glycated Albumin Sales by Region: 2019-2024
3.2.2 Global Glycated Albumin Sales by Region: 2025-2030
3.3 Global Glycated Albumin Global Glycated Albumin Revenue by Region: 2019-2030
3.3.1 Global Glycated Albumin Revenue by Region: 2019-2024
3.3.2 Global Glycated Albumin Revenue by Region: 2025-2030
3.4 North America Glycated Albumin Market Facts & Figures by Country
3.4.1 North America Glycated Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Glycated Albumin Sales by Country (2019-2030)
3.4.3 North America Glycated Albumin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Glycated Albumin Market Facts & Figures by Country
3.5.1 Europe Glycated Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Glycated Albumin Sales by Country (2019-2030)
3.5.3 Europe Glycated Albumin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glycated Albumin Market Facts & Figures by Country
3.6.1 Asia Pacific Glycated Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Glycated Albumin Sales by Country (2019-2030)
3.6.3 Asia Pacific Glycated Albumin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Glycated Albumin Market Facts & Figures by Country
3.7.1 Latin America Glycated Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Glycated Albumin Sales by Country (2019-2030)
3.7.3 Latin America Glycated Albumin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glycated Albumin Market Facts & Figures by Country
3.8.1 Middle East and Africa Glycated Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Glycated Albumin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Glycated Albumin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Glycated Albumin Sales by Type (2019-2030)
4.1.1 Global Glycated Albumin Sales by Type (2019-2024)
4.1.2 Global Glycated Albumin Sales by Type (2025-2030)
4.1.3 Global Glycated Albumin Sales Market Share by Type (2019-2030)
4.2 Global Glycated Albumin Revenue by Type (2019-2030)
4.2.1 Global Glycated Albumin Revenue by Type (2019-2024)
4.2.2 Global Glycated Albumin Revenue by Type (2025-2030)
4.2.3 Global Glycated Albumin Revenue Market Share by Type (2019-2030)
4.3 Global Glycated Albumin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Glycated Albumin Sales by Application (2019-2030)
5.1.1 Global Glycated Albumin Sales by Application (2019-2024)
5.1.2 Global Glycated Albumin Sales by Application (2025-2030)
5.1.3 Global Glycated Albumin Sales Market Share by Application (2019-2030)
5.2 Global Glycated Albumin Revenue by Application (2019-2030)
5.2.1 Global Glycated Albumin Revenue by Application (2019-2024)
5.2.2 Global Glycated Albumin Revenue by Application (2025-2030)
5.2.3 Global Glycated Albumin Revenue Market Share by Application (2019-2030)
5.3 Global Glycated Albumin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Asahi Kasei Pharma
6.1.1 Asahi Kasei Pharma Corporation Information
6.1.2 Asahi Kasei Pharma Description and Business Overview
6.1.3 Asahi Kasei Pharma Glycated Albumin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Asahi Kasei Pharma Glycated Albumin Product Portfolio
6.1.5 Asahi Kasei Pharma Recent Developments/Updates
6.2 DIAZYME
6.2.1 DIAZYME Corporation Information
6.2.2 DIAZYME Description and Business Overview
6.2.3 DIAZYME Glycated Albumin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 DIAZYME Glycated Albumin Product Portfolio
6.2.5 DIAZYME Recent Developments/Updates
6.3 Abnova
6.3.1 Abnova Corporation Information
6.3.2 Abnova Description and Business Overview
6.3.3 Abnova Glycated Albumin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abnova Glycated Albumin Product Portfolio
6.3.5 Abnova Recent Developments/Updates
6.4 LifeSpan
6.4.1 LifeSpan Corporation Information
6.4.2 LifeSpan Description and Business Overview
6.4.3 LifeSpan Glycated Albumin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 LifeSpan Glycated Albumin Product Portfolio
6.4.5 LifeSpan Recent Developments/Updates
6.5 Exocell
6.5.1 Exocell Corporation Information
6.5.2 Exocell Description and Business Overview
6.5.3 Exocell Glycated Albumin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Exocell Glycated Albumin Product Portfolio
6.5.5 Exocell Recent Developments/Updates
6.6 BSBE
6.6.1 BSBE Corporation Information
6.6.2 BSBE Description and Business Overview
6.6.3 BSBE Glycated Albumin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BSBE Glycated Albumin Product Portfolio
6.6.5 BSBE Recent Developments/Updates
6.7 Medicalsystem
6.6.1 Medicalsystem Corporation Information
6.6.2 Medicalsystem Description and Business Overview
6.6.3 Medicalsystem Glycated Albumin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Medicalsystem Glycated Albumin Product Portfolio
6.7.5 Medicalsystem Recent Developments/Updates
6.8 Maccura
6.8.1 Maccura Corporation Information
6.8.2 Maccura Description and Business Overview
6.8.3 Maccura Glycated Albumin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Maccura Glycated Albumin Product Portfolio
6.8.5 Maccura Recent Developments/Updates
6.9 Leadman
6.9.1 Leadman Corporation Information
6.9.2 Leadman Description and Business Overview
6.9.3 Leadman Glycated Albumin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Leadman Glycated Albumin Product Portfolio
6.9.5 Leadman Recent Developments/Updates
6.10 Simes Sikma
6.10.1 Simes Sikma Corporation Information
6.10.2 Simes Sikma Description and Business Overview
6.10.3 Simes Sikma Glycated Albumin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Simes Sikma Glycated Albumin Product Portfolio
6.10.5 Simes Sikma Recent Developments/Updates
6.11 NINGBO PUREBIO
6.11.1 NINGBO PUREBIO Corporation Information
6.11.2 NINGBO PUREBIO Glycated Albumin Description and Business Overview
6.11.3 NINGBO PUREBIO Glycated Albumin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 NINGBO PUREBIO Glycated Albumin Product Portfolio
6.11.5 NINGBO PUREBIO Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glycated Albumin Industry Chain Analysis
7.2 Glycated Albumin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glycated Albumin Production Mode & Process
7.4 Glycated Albumin Sales and Marketing
7.4.1 Glycated Albumin Sales Channels
7.4.2 Glycated Albumin Distributors
7.5 Glycated Albumin Customers
8 Glycated Albumin Market Dynamics
8.1 Glycated Albumin Industry Trends
8.2 Glycated Albumin Market Drivers
8.3 Glycated Albumin Market Challenges
8.4 Glycated Albumin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
